Industry prepares for war-related problems

Given Imaging shifts inventory overseas in light of conflict.

By SHARON WROBEL
July 21, 2006 08:10
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Given Imaging, which develops a tiny camera in a pill that is used to diagnose digestive ailments, has emerged as one of the first companies to disclose alternative plans should the violence in the North impact business. "We have a back-up production facility in Ireland that can be utilized immediately for full production if necessary," Given said. Given, which has headquarters, manufacturing, and R&D facilities that are based in Yokne'am, said it has shifted inventory of its Pillcam capsule endoscopes to the US and Europe in light of the current situation. Given has direct sales and marketing operations in the US, Germany and France and local offices in Japan, Spain and Australia. Other companies with manufacturing facilities in Israel are continuing their operations and production as long as possible while preparing for alternative channels in case of further escalation. "Audiocodes and Radware currently manufacture in northern Israel and, while they are yet to feel any impact, are at high risk of disruptions," said Haim Israel, research analyst at Merrill Lynch. Israel noted that Audiocodes was using Flextronics' facility in Migdal-Ha'emek, a few miles away from the areas under attack, while Radware partially manufactures in Karmiel. "Our main production facilities are in Jerusalem and if need be we can fully move our Karmiel outsourcing operations to Jerusalem," Meir Moshe, CFO of Radware told The Jerusalem Post. "In case of further continued escalation of over 60 days, we could resort to our facilities in the United States and Europe. But I don't see that happening." Meanwhile, Amdocs Israel has said the Ra'anana-based company remained unaffected by the recent escalations and that it had plans in place to ensure continued services for its customers. Intel, which has an R&D facility in Haifa confirmed to the Post that all efforts were in place to enable the continuation of production and services in Israel. "We are doing everything for work to continue - if it is working from home or elsewhere."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS